...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A.
【24h】

Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A.

机译:儿童急性髓性白血病的基因突变,特别是ASXL1,TET2,IDH1,IDH2和DNMT3A突变的特殊参考。

获取原文
获取原文并翻译 | 示例

摘要

Gene mutations involving epigenetic regulators recently have been described in adult acute myeloid leukemia (AML). Similar studies are limited in children. We analyzed gene mutations and cooperation in pediatric AML with special reference on mutated epigenetic regulators. Nineteen gene mutations, including 8 class I genes, 4 class II genes, WT1 and TP53 (class III), and 5 epigenetic regulator genes (class IV), were analyzed in 206 children with de novo AML. Mutational analysis was performed with polymerase chain reaction-based assay followed by direct sequencing. One hundred seventeen of 206 patients (56.8%) had at least one mutation: 51% class I, 13% class II, 6.8% class III, and 5.6% class IV. FLT3-internal tandem duplication was most frequent, and 29% of patients had more than one gene mutation. Two patients carried ASXL1 mutations, both with t(8;21), 2 had DNMT3A mutations, 2 had IDH1 mutations, 1 had IDH2 mutation, and 3 had TET2 mutations. Both patients with IDH1 mutations had AML-M0 subtype and MLL-partial tandem duplication. Cooperating mutations with mutated epigenetic regulators were observed in 8 of 10 patients. We conclude that mutated epigenetic regulators were much less than those in adult AML but with frequent cooperating mutations. ASXL1, TET2, and IDH1 mutations were associated with specific genetic subtypes.
机译:最近涉及表观遗传调节剂的基因突变已在成人急性髓性白血病(AML)中描述。类似的研究有限于儿童。我们在突变的表观遗传调节剂的特殊参考中分析了小儿AML中的基因突变和合作。在206例患有De Novo AML的206名儿童中分析了19个基因突变,包括8类基因,4类基因,WT1和TP53(III类)和5级表观遗传调节基因(IV类)。通过基于聚合酶链反应的测定进行突变分析,然后直接测序。 206名患者(56.8%)的一百七十岁突变至少有一个突变:51%,II级,II级,III级6.8%,5.6%等级。 FLT3-内部串联复制最常见,29%的患者具有多种基因突变。两名患者携带ASOX11突变,均具有T(8; 21),2具有DNMT3A突变,2具有IDH1突变,1个具有IDH2突变,并且3具有TET2突变。两种患有IDH1突变的患者都有AML-M0亚型和MLL部分串联复制。在10名患者中观察到具有突变的表观遗传调节剂的合作突变。我们得出结论,突变的表观遗传调节剂远低于成人AML的表观遗传调节剂,但频繁的合作突变。 ASXL1,TET2和IDH1突变与特定的遗传亚型相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号